• About
  • Subscribe
  • Advertise
  • Contact
Friday, May 16, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Hope for ‘tactile’ RATs for vision impaired

by rhiannon bowman
February 14, 2022
in Local, News
Reading Time: 3 mins read
A A
Rapid Antigen Test instructions are only provided in print and the results are presented visually.

Rapid Antigen Test instructions are only provided in print and the results are presented visually.

Share on FacebookShare on Twitter

Vision 2020 Australia is working closely with its members to inform the federal government that Rapid Antigen Tests (RATs) are inaccessible to people who are blind or vision impaired and is proposing potential solutions.

“These tests are inaccessible to people who are blind or have vision loss, because the test results are presented visually, the processes are often complex, and the instructions are only provided in print,” the organisation said.

Separate organisation – Vision Australia – has also called on the government to implement further measures to ensure the vision impaired community can get access to results in a timely manner, ABC News reported.

Vision 2020 Australia acknowledged federal and state governments have this year been transitioning toward RATs to screen for COVID-19, in order to minimise pressure on PCR testing sights.

“We appreciate steps already taken, such as the provision of free tests to holders of concession cards, and the recently introduced capacity for NDIS participants to purchase tests using their plan funding,” the organisation stated.

In terms of potential solutions, Vision 2020 said services such as Aira and Be My Eyes – apps that connect blind and low-vision people with sighted people who can visually interpreting the former’s surroundings – may be helpful for some.

“Both offer free assistance in completing Rapid Antigen Tests. However, these services rely on smartphones, internet, and technical literacy, so are not a solution for all people,” Vision 2020 said.

Aira is offering 30 minutes free COVID-19 related assistance, including reading out RAT instructions and results.

Aira’s director of customer communication Jenine Stanley told Vision Australia that difficulties with RATs was a common concern.

“We really started hearing from people that these tests are not accessible at all, there’s very little material online, they’re a very difficult physical test to do because there are a lot of fiddly parts,” she said.

In the interim, Vision 2020 Australia is calling for increased national access to PCR tests at home, similar to the ‘Call-to-test’ system currently available in Victoria, as well as a mailout system to provide free RATs for people with disabilities including vision loss.

Longer term, Vision 2020 believes the solution is innovation.

“The Royal National Institute of Blind People [in the UK] recently released a prototype pregnancy test which delivers results in tactile rather than visual form. This proves it is possible to design accessible Rapid Antigen Tests, and we hope to see these widely available in the future.”

More reading 

FDA breakthrough for Australian bionic eye

Vision 2020 Australia sets sights on future goals at 21st birthday

 

 

Tags: blind and vision impairedRapid Antigen TestRATVision 2020 AustraliaVision Australia

Related Posts

The cost of intravitreal eye injections to manage macular degeneration can discourage many older Australians from continuing treatment. Image: Rose Makin/stock.adobe.com.

Special Report: Intravitreal injections and bulk billing – good for business

by Rob Mitchell
May 16, 2025

Frequent intravitreal injections are vital to help many older Australians keep their eyesight, but the costs can be prohibitive. Insight...

A scene from the movie My Eyes, featuring optometrist Tsu Shan Chambers (right). Image: FanForce Films.

My Eyes film starring Australian optometrist set to open in theatres

by Staff Writer
May 16, 2025

A film highlighting the remarkable journey of a Australian mother determined to save her daughter’s eyesight, and starring a practising...

Dry eye disease affects more than 4 million Australians and one symptom can be chronic eye pain. Image: sruilk/Shutterstock.com.

Aussie link in research on device to combat chronic eye pain

by Staff Writer
May 16, 2025

Research involving Australian patients has returned positive results for a device intended for the treatment of chronic ocular surface pain...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited